238 related articles for article (PubMed ID: 22674488)
1. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
5. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
Arthritis Res Ther; 2011 Jul; 13(4):R126. PubMed ID: 21801431
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
7. Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.
Kosmaczewska A; Ciszak L; Swierkot J; Szteblich A; Kosciow K; Frydecka I
Inflammation; 2015 Apr; 38(2):765-74. PubMed ID: 25145773
[TBL] [Abstract][Full Text] [Related]
8. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
Szalay B; Vásárhelyi B; Cseh A; Tulassay T; Deák M; Kovács L; Balog A
Clin Rheumatol; 2014 Feb; 33(2):175-85. PubMed ID: 23934385
[TBL] [Abstract][Full Text] [Related]
9. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.
Kosmaczewska A; Swierkot J; Ciszak L; Szteblich A; Chrobak A; Karabon L; Partyka A; Szechinski J; Wiland P; Frydecka I
Rheumatol Int; 2014 Feb; 34(2):243-53. PubMed ID: 24221190
[TBL] [Abstract][Full Text] [Related]
10. Leonurine Regulates Treg/Th17 Balance to Attenuate Rheumatoid Arthritis Through Inhibition of TAZ Expression.
Du YY; Chen ZX; Liu MY; Liu QP; Lin CS; Chu CQ; Xu Q
Front Immunol; 2020; 11():556526. PubMed ID: 33117342
[TBL] [Abstract][Full Text] [Related]
11. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.
Hull DN; Williams RO; Pathan E; Alzabin S; Abraham S; Taylor PC
Clin Exp Immunol; 2015 Sep; 181(3):401-6. PubMed ID: 25766640
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
[TBL] [Abstract][Full Text] [Related]
14. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients.
Yue C; You X; Zhao L; Wang H; Tang F; Zhang F; Zhang X; He W
Rheumatol Int; 2010 Nov; 30(12):1553-7. PubMed ID: 19847432
[TBL] [Abstract][Full Text] [Related]
15. Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept.
Blache C; Lequerré T; Roucheux A; Beutheu S; Dedreux I; Jacquot S; Le Loët X; Boyer O; Vittecoq O
Rheumatology (Oxford); 2011 Oct; 50(10):1814-22. PubMed ID: 21791546
[TBL] [Abstract][Full Text] [Related]
16. Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
Jin S; Chen H; Li Y; Zhong H; Sun W; Wang J; Zhang T; Ma J; Yan S; Zhang J; Tian Q; Yang X; Wang J
Ann Rheum Dis; 2018 Nov; 77(11):1644-1652. PubMed ID: 30045854
[TBL] [Abstract][Full Text] [Related]
17. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
Santinon F; Batignes M; Mebrek ML; Biton J; Clavel G; Hervé R; Lemeiter D; Breckler M; Busato F; Tost J; Ziol M; Boissier MC; Decker P; Semerano L; Bessis N
Arthritis Rheumatol; 2020 Apr; 72(4):576-587. PubMed ID: 31609517
[TBL] [Abstract][Full Text] [Related]
19. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
[TBL] [Abstract][Full Text] [Related]
20. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]